Skip to main content
The Cochrane Database of Systematic Reviews logoLink to The Cochrane Database of Systematic Reviews
. 2012 Apr 18;2012(4):CD004569. doi: 10.1002/14651858.CD004569.pub3

Second or third additional chemotherapy drug for non‐small cell lung cancer in patients with advanced disease

Catherine Delbaldo 1, Stefan Michiels 2, Estelle Rolland 3, Nathalie Syz 4, Jean‐Charles Soria 5, Thierry Le Chevalier 1, Jean Pierre Pignon 6,
Editor: Cochrane Lung Cancer Group
PMCID: PMC10655042  PMID: 22513924

Reason for withdrawal from publication

Review withdrawn from publication as there is no progress with its update.

The editorial group responsible for this previously published document have withdrawn it from publication.

What's new

Date Event Description
8 March 2012 Amended Review withdrawn from publication.

History

Protocol first published: Issue 1, 2005
 Review first published: Issue 4, 2007

Date Event Description
18 September 2008 Amended Converted to new review format.
16 August 2007 New citation required and conclusions have changed Substantive amendment

Sources of support

Internal sources

  • Instutit Gustave Roussy, France.

External sources

  • Aventis, France.

Withdrawn from publication for reasons stated in the review


Articles from The Cochrane Database of Systematic Reviews are provided here courtesy of Wiley

RESOURCES